Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Accenture
Moodys
Cerilliant
Mallinckrodt
Teva
Chubb
UBS

Generated: June 25, 2018

DrugPatentWatch Database Preview

Cefpodoxime proxetil - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for cefpodoxime proxetil and what is the scope of cefpodoxime proxetil freedom to operate?

Cefpodoxime proxetil
is the generic ingredient in three branded drugs marketed by Sankyo, Aurobindo Pharma Ltd, Sandoz, Sun Pharm Inds Ltd, Pharmacia And Upjohn, Aurobindo Pharma, and Orchid Hlthcare, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for cefpodoxime proxetil. Nine suppliers are listed for this compound.
Pharmacology for cefpodoxime proxetil
Synonyms for cefpodoxime proxetil
(+-)-1-Hydroxyethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), isopropyl carbonate (ester)
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester
(E)-Cefpodoxime Proxetil
(RS)-1-((Isopropoxycarbonyl)oxy)ethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
(RS)1(isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3methoxymethyl-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate
1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7-{[(2Z)-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate
1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl 7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-propan-2-yloxycarbonyloxyethyl 7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
239C814
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester,(6R-(6-alpha,7-beta(Z)))-
87239-81-4
947692-13-9
AB01209734-01
AB01563099_01
AC1L1E55
AC1L9B34
AC1NS49S
AC1O426I
AC1O6HBL
AK322023
AKOS015994692
AKOS030242963
AN-7622
Antibiotic CS 807
API0001908
Banan
BRD-A87387433-001-01-9
C08115
C21H27N5O9S2
CAS-87239-81-4
CC0150
CCG-100877
CCG-213498
CCG-221250
Cefodox
Cefoprox
cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester
Cefpodoxime proxetil (JP17/USP)
Cefpodoxime proxetil [USAN:JAN]
Cefpodoxime proxetil [USAN:USP:JAN]
Cefpodoxime Proxetil EP Impurity D
CEFPODOXIME PROXETIL, VANTIN
Cefpodoximeproxetil
Cefpodoximproxetil
cephalosporin 807
Cephpodoxime Proxetil
Cepodem
CHEBI:3505
CHEBI:94455
CHEMBL1201016
CPD000469193
CS 807
CS-807
CTK7B2648
CTK8F8535
D00920
Doxef
DR003263
DSSTox_CID_2766
DSSTox_GSID_22766
DSSTox_RID_76722
DTXSID1022766
HE399637
HMS2051M14
HMS2093B08
HMS2231C24
HMS3374C02
HMS3393M14
K558
KS-1149
LS-150022
LTINZAODLRIQIX-FBXRGJNPSA-N
MFCD00865088
MLS001401428
MolPort-003-845-692
MolPort-023-220-360
NC00127
NCGC00164598-01
NCGC00183131-01
NSC-759161
NSC759161
Orelox
Otreon
Pharmakon1600-01505637
Podomexef
RU-51807
SAM001246674
SBI-0206821.P001
SCHEMBL27071
SCHEMBL379709
Simplicef
Simplicef [Veterinary]
SMR000469193
SR-05000001937
SR-05000001937-1
STL454343
STL454350
Tox21_113377
Tox21_113428
U 76252
U-76,252
U-76252
Vantin
Xtum-O
ZINC15449381

US Patents and Regulatory Information for cefpodoxime proxetil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare CEFPODOXIME PROXETIL cefpodoxime proxetil TABLET;ORAL 065388-002 Nov 14, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CEFPODOXIME PROXETIL cefpodoxime proxetil TABLET;ORAL 065462-002 May 28, 2008 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sankyo BANAN cefpodoxime proxetil TABLET;ORAL 050687-001 Aug 7, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn VANTIN cefpodoxime proxetil FOR SUSPENSION;ORAL 050675-001 Aug 7, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Teva
Boehringer Ingelheim
Colorcon
Citi
Chubb
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.